Hcw Biologics Stock Forecast

Sell candidate since Jul 01, 2026 Loss -28.60%

The HCW Biologics Inc. stock price fell by -4.11% on the last day (Monday, 10th Aug 2026) from $3.41 to $3.27. During the last trading day the stock fluctuated 11.34% from a day low at $3.22 to a day high of $3.59. The price has fallen in 5 of the last 10 days but is still up by 23.4% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -12 thousand shares and in total, 39 thousand shares were bought and sold for approximately $127.96 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

HCWB Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The HCW Biologics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.38 and $4.19. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 22, 2026, and so far it has fallen -81.14%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for HCW Biologics Inc. stock

HCW Biologics Inc. finds support from accumulated volume at $3.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.365 between high and low, or 11.34%. For the last week the stock has had daily average volatility of 11.58%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HCWB) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect HCW Biologics Inc. to open at $3.36, and during the day (based on 14 day Average True Range), to move between $2.98 and $3.56, which gives a possible trading interval of +/-$0.571 (+/-19.13%) up or down from last closing price. If HCW Biologics Inc. takes out the full calculated possible swing range there will be an estimated 19.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.34 (2.14%) than the support at $3.15 (3.67%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is HCW Biologics Inc. stock A Buy?

HCW Biologics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.386 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $3.36 ( 2.70%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk